Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>Epigallocatechin‐3‐gallate (EGCG), the major polyphenol found in green tea, exerts multiple protective effects against cardiovascular diseases, including cardiac hypertrophy. However, the molecular mechanism underlying its anti‐hypertrophic effect has not been clarified. This study revealed that EGCG could inhibit pressure overload‐induced cardiac hypertrophy by regulating the PSMB5/Nmnat2/SIRT6‐dependent signaling pathway.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Quantitative real‐time polymerase chain reaction and western blotting were used to determine the expression of mRNA and protein, respectively. A fluorometric assay kit was used to determine the activity of SIRT6, a histone deacetylase. Luciferase reporter gene assay and electrophoretic mobility shift assay were employed to measure transcriptional activity and DNA binding activity, respectively.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>EGCG could significantly increase Nmnat2 protein expression and enzyme activity in cultured neonatal rat cardiomyocytes stimulated with angiotensinⅡ (AngⅡ) and heart tissues from rats subjected to abdominal aortic constriction. Nmnat2 knockdown by RNA interference attenuated the inhibitory effect of EGCG on cardiac hypertrophy. EGCG blocked NF‐κB DNA binding activity induced by AngⅡ, which was dependent on Nmnat2 and the subsequent SIRT6 activation. Moreover, the activation of PSMB5 (20S proteasome subunit β‐5, chymotrypsin‐like) was required for EGCG‐induced Nmnat2 protein expression. Additionally, we demonstrated that EGCG might interact with PSMB5 and inhibit the activation of the proteasome.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>These findings serve as the first evidence that the effect of EGCG against cardiac hypertrophy may be, at least partially, attributed to the modulation of the PSMB5/Nmnat2‐dependent signaling pathway, suggesting the therapeutic potential of EGCG in the prevention and treatment of cardiac hypertrophy.</p></section>

EGCG Inhibits Cardiomyocyte Apoptosis in Pressure Overload-Induced Cardiac Hypertrophy and Protects Cardiomyocytes from Oxidative Stress in Rats

Egcg Inhibits Proliferation of Cardiac Fibroblasts in Rats with Cardiac Hypertrophy

Epigallocatechin-3 Gallate, a Green Tea Catechin, Attenuated the Downregulation of the Cardiac Gap Junction Induced by High Glucose in Neonatal Rat Cardiomyocytes

Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.

Epigallocatechin Gallate Protects H9c2 Cardiomyoblasts Against Hydrogen Dioxides- Induced Apoptosis and Telomere Attrition

EGCG Inhibition Against Collagen Accumulation and Cell Proliferation in Cardiac Hypertrophy

(-)-Epigallocatechin-3-gallate Attenuates Myocardial Injury Induced by Ischemia/Reperfusion in Diabetic Rats and in H9c2 Cells under Hyperglycemic Conditions

EGCG inhibits pressure overload‐induced cardiac hypertrophy via the PSMB5/Nmnat2/SIRT6‐dependent signalling pathways

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway

Cardioprotective Effects of Epigallocatechin-3-gallate Against Doxorubicin-Induced Cardiomyocyte Injury.

Epigallocatechin Gallate, the Major Component of Polyphenols in Green Tea, Inhibits Telomere Attrition Mediated Cardiomyocyte Apoptosis in Cardiac Hypertrophy

Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.

Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats

The Effect of EGCG on Myocardial Cell Apoptosis in Mice induced by DOX

(-)-Epigallocatechin Gallate Promotes MicroRNA 145 Expression against Myocardial Hypoxic Injury through Dab2/Wnt3a/ β -catenin.

Mitochondria-targeting EGCG derivatives protect H9c2 cardiomyocytes from H2O2-induced apoptosis: design, synthesis and biological evaluation

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition

(-)-Epigallocatechin Gallate Promotes Microrna 145 Expression Against Myocardial Hypoxic Injury Through Dab2/Wnt3a/Beta-Catenin

EGCG protects vascular endothelial cells from oxidative stress-induced damage by targeting the autophagy-dependent PI3K-AKT-mTOR pathway

Cardiac protection of prostacyclin secreted from endothelial progenitor cells against oxidative stress-induced apoptosis：verified by cardiac electrophysiological tests